Drug delivery with carbon nanotubes for in vivo cancer treatment

Open access

Zhuang Liu, Kai Chen, Corrine R. Davis, Sarah P. Sherlock, Qizhen Cao, Xiaoyuan Shawn Chen, Hongjie Dai·2008·PubMed

DOI 10.48550/arxiv.0808.2070arXiv 0808.2070

Open this paper in CoChat — free account

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

OpenAlex · 10.48550/arxiv.0808.2070

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Pharmacological inhibition of cystine-glutamate exchange induces endoplasmic reticulum stress and ferroptosis
Dixon, S. J., Patel, D. N., Welsch, M., Skouta, R., Lee, E. D., Hayano, M., Thomas, A. G., Gleason, C. E., Tatonetti, N. P., Slusher, B. S., et al. (2014) · eLife · doi:10.7554/elife.02523 · Cited by 2,088
Physical limits of cell migration: control by ECM space and nuclear deformation and tuning by proteolysis and traction force
Wolf, K., te Lindert, M., Krause, M., Alexander, S., te Riet, J., Willis, A. L., Hoffman, R. M., Figdor, C. G., Weiss, S. J., & Friedl, P. (2013) · Journal of Cell Biology · doi:10.1083/jcb.201210152 · Cited by 1,375
A route to brightly fluorescent carbon nanotubes for near-infrared imaging in mice
Welsher, K., Liu, Z., Sherlock, S. P., Robinson, J. T., Chen, Z., Daranciang, D., & Dai, H. (2009) · Nature Nanotechnology · doi:10.1038/nnano.2009.294 · Cited by 1,287
Self-citation
Carbon nanotubes: properties, synthesis, purification, and medical applications
Eatemadi, A., Daraee, H., Karimkhanloo, H., Kouhi, M., Zarghami, N., Akbarzadeh, A., Abasi, M., Hanifehpour, Y., & Joo, S. W. (2014) · Nanoscale Research Letters · doi:10.1186/1556-276x-9-393 · Cited by 1,239
SOCS3, a Major Regulator of Infection and Inflammation
Carow, B., & Rottenberg, M. E. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00058 · Cited by 555
Metformin Therapy and Risk of Cancer in Patients with Type 2 Diabetes: Systematic Review
Franciosi, M., Lucisano, G., Lapice, E., Strippoli, G. F. M., Pellegrini, F., & Nicolucci, A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0071583 · Cited by 428
Angiopoietin-Like Proteins: A Comprehensive Look
Santulli, G. (2014) · Frontiers in Endocrinology · doi:10.3389/fendo.2014.00004 · Cited by 320
Therapeutically activating RB: reestablishing cell cycle control in endocrine therapy-resistant breast cancer
Thangavel, C., Dean, J. L., Ertel, A., Knudsen, K. E., Aldaz, C. M., Witkiewicz, A. K., Clarke, R., & Knudsen, E. S. (2011) · Endocrine Related Cancer · doi:10.1530/erc-10-0262 · Cited by 302
The Extrinsic and Intrinsic Roles of PD‐L1 and Its Receptor PD‐1: Implications for Immunotherapy Treatment
Hudson, K., Cross, N., Jordan-Mahy, N., & Leyland, R. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.568931 · Cited by 243
Role of vascular normalization in benefit from metronomic chemotherapy
Mpekris, F., Baish, J. W., Stylianopoulos, T., & Jain, R. K. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1700340114 · Cited by 178
A Review of Dietary Phytochemicals and Their Relation to Oxidative Stress and Human Diseases
Guan, R., Van Le, Q., Yang, H., Zhang, D., Gu, H., Yang, Y., Sonne, C., Lam, S. S., Zhong, J., Jianguang, Z., et al. (2021) · Chemosphere · doi:10.1016/j.chemosphere.2020.129499 · Cited by 169
Recent advances of highly selective CDK4/6 inhibitors in breast cancer
Xu, H., Yu, S., Liu, Q., Yuan, X., Mani, S., Pestell, R. G., & Wu, K. (2017) · Journal of Hematology & Oncology · doi:10.1186/s13045-017-0467-2 · Cited by 168
Immunosenescence and cancer
Pawelec, G. (2017) · Biogerontology · doi:10.1007/s10522-017-9682-z · Cited by 140
Tumor organoid models in precision medicine and investigating cancer-stromal interactions
Xu, R., Zhou, X., Wang, S., & Trinkle, C. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107668 · Cited by 134
Colorectal cancer and immunity: What we know and perspectives
Pernot, S. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i14.3738 · Cited by 131
Transient and stable vector transfection: Pitfalls, off-target effects, artifacts
Stepanenko, A. A., & Heng, H. H. (2017) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2017.05.002 · Cited by 109
Primary and acquired resistance to EGFR-targeted therapies in colorectal cancer: impact on future treatment strategies
Leto, S. M., & Trusolino, L. (2014) · Journal of Molecular Medicine · doi:10.1007/s00109-014-1161-2 · Cited by 87
Telomeres, telomerase and colorectal cancer
Bertorelle, R. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i8.1940 · Cited by 82
HAMdb: a database of human autophagy modulators with specific pathway and disease information
Wang, N.-N., Dong, J., Zhang, L., Ouyang, D., Cheng, Y., Chen, A. F., Lu, A.-P., & Cao, D.-S. (2018) · Journal of Cheminformatics · doi:10.1186/s13321-018-0289-4 · Cited by 83
PIM kinases: From survival factors to regulators of cell motility
Santio, N. M., & Koskinen, P. J. (2017) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2017.10.016 · Cited by 69
Heparanase, cell signaling, and viral infections
Koganti, R., Suryawanshi, R., & Shukla, D. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03559-y · Cited by 67
miRNA-338-3p suppresses cell growth of human colorectal carcinoma by targeting smoothened
Sun, K. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i14.2197 · Cited by 58
Evaluating optimal therapy robustness by virtual expansion of a sample population, with a case study in cancer immunotherapy
Barish, S., Ochs, M. F., Sontag, E. D., & Gevertz, J. L. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1703355114 · Cited by 48
Phospholipase A2-Responsive Phosphate Micelle-Loaded UCNPs for Bioimaging of Prostate Cancer Cells
Sharipov, M., Tawfik, S. M., Gerelkhuu, Z., Huy, B. T., & Lee, Y.-I. (2017) · Scientific Reports · doi:10.1038/s41598-017-16136-4 · Cited by 52
Targeting mutant p53-expressing tumours with a T cell receptor-like antibody specific for a wild-type antigen
Low, L., Goh, A., Koh, J., Lim, S., & Wang, C.-I. (2019) · Nature Communications · doi:10.1038/s41467-019-13305-z · Cited by 48
CD47-targeted bismuth selenide nanoparticles actualize improved photothermal therapy by increasing macrophage phagocytosis of cancer cells
Guo, Z., Liu, Y., Zhou, H., Zheng, K., Wang, D., Jia, M., Xu, P., Ma, K., Cui, C., & Wang, L. (2019) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2019.110546 · Cited by 48
Radiomic mapping model for prediction of Ki-67 expression in adrenocortical carcinoma
Ahmed, A. A., Elmohr, M. M., Fuentes, D., Habra, M. A., Fisher, S. B., Perrier, N. D., Zhang, M., & Elsayes, K. M. (2020) · Clinical Radiology · doi:10.1016/j.crad.2020.01.012 · Cited by 41
High ATF4 expression is associated with poor prognosis, amino acid metabolism, and autophagy in gastric cancer
Wang, M., Lu, Y., Wang, H., Wu, Y., Xu, X., & Li, Y. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.740120 · Cited by 36
Tumor microenvironment and the role of mesenchymal stromal cells
KUCEROVA, L., & SKOLEKOVA, S. (2012) · Neoplasma · doi:10.4149/neo_2013_001 · Cited by 27
Thrombospondin-1 in a Murine Model of Colorectal Carcinogenesis
Lopez-Dee, Z. P., Chittur, S. V., Patel, H., Chinikaylo, A., Lippert, B., Patel, B., Lawler, J., & Gutierrez, L. S. (2015) · PLOS ONE · doi:10.1371/journal.pone.0139918 · Cited by 23
PCC0208023, a potent SHP2 allosteric inhibitor, imparts an antitumor effect against KRAS mutant colorectal cancer
Chen, X., Zou, F., Hu, Z., Du, G., Yu, P., Wang, W., Wang, H., Ye, L., & Tian, J. (2020) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2020.115019 · Cited by 20
Self-citation
Inhibition of proliferation and migration of tumor cells through phenylboronic acid-functionalized polyamidoamine-mediated delivery of a therapeutic DNAzyme Dz13
Yang, J., Zhang, J., Xing, J., Shi, Z., Han, H., & Li, Q. (2019) · International Journal of Nanomedicine · doi:10.2147/ijn.s211744 · Cited by 11
IPIAD- an augmentation regimen added to standard treatment of pancreatic ductal adenocarcinoma using already-marketed repurposed drugs irbesartan, pyrimethamine, itraconazole, azithromycin, and dapsone
Kast, R. E. (2024) · Oncoscience · doi:10.18632/oncoscience.594 · Cited by 6

Authors: Liu, Z., Chen, K., Davis, C. R., Sherlock, S. P., Cao, Q., Chen, X. S., & Dai, H.
Venue: PubMed
Publisher: National Institutes of Health
Published: 2008-08-14
Volume: 68
Issue: 16
Pages: 6652-60
DOI: 10.48550/arxiv.0808.2070
arXiv: 0808.2070
OpenAlex: W1523071718
Cited by: 2,286
References: 0
FWCI: 7.71
Type: journal article
Language: en
Open access: green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review